MADRIGAL PHARMACEUTICALS, INC. Decrease in Restricted Cash
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Decrease in Restricted Cash of $83.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes
us-gaap:DecreaseInRestrictedCash · last filed 2019-02-27
- MADRIGAL PHARMACEUTICALS, INC. decrease in restricted cash for fiscal 2016 was $83.00K.
| Period end | Decrease in Restricted Cash 12 month | Decrease in Restricted Cash 12 month as first filed |
|---|---|---|
| 2016-12-31 | $83.00K 10-K · filed 2019-02-27 | $82.50K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |